FDA Looks for Public Comment About Descheduling Cannabis

The U.S. Food and Drug Administration (FDA) is seeking public comment (yep, that means you) regarding the classification of marijuana as a Schedule I substance under both U.S. law and international drug agreements. The FDA is putting together a recommendation for the United Nations’ World Health Organization (WHO). WHO is currently reviewing the international classification of cannabis, including THC, CBD and other cannabinoids.

Cannabis was listed in the UN’s Single Convention on Narcotic Drugs as a Schedule I drug in 1961, and the WHO says that cannabis is “the most commonly used psychoactive substance under international control.” Schedule I drugs include LSD and heroin–drugs that are considered high risk for abuse and addiction and that have no currently accepted medical use.

The FDA is specifically looking for input regarding the “abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on availability for medical use of” marijuana. The FDA will forward public comments to the United Nations World Health Organization (WHO). Recommendations from the WHO are used to inform public health policy and drug laws.

In December, the WHO released a preliminary review of CBD, a non-psychoactive compound found in marijuana, that said CBD should not be scheduled as a controlled substance. They concluded that CBD has a low potential for abuse and that it “has been demonstrated as an effective treatment of epilepsy in several clinical trials” and “is generally well tolerated with a good safety profile.”

The preliminary review also found that “there is no evidence of…any public health related problems associated with the use of pure CBD.”

The deadline to submit public comments to the FDA is April 23.

Want to support the declassification of cannabis, but you don’t know where to start? NORML has posted a pre-drafted comment on their website, and they will be hand delivering all comments to the FDA.


Related Articles

Advocate & CBD Spa Owner Cindy Sovine Fights for Initiative 300, Cannabis Rights

Advocate & CBD Spa Owner Cindy Sovine Fights for Initiative 300, Cannabis Rights

Initiative 300's Long Hard Road The fight over cannabis related social consumption here in[...]

Read More »
How to Invest in Hemp Farms

How to Invest in Hemp Farms

Americans have all wanted to know how to invest in hemp farms since the 2018[...]

Read More »
0420 Inc. Launches CannabisAMP.com!

0420 Inc. Launches CannabisAMP.com!

The Cannabis Industry Amplifier You've probably heard us talk about content creators at one of[...]

Read More »
Free Download

Join Our Network Today!

Join 0420 Inc. today and receive 5 Ways to Get Into the Industry - FREE Download

Get Started Today!

Interested In:

Please Enter the Code (required)
captcha

@0420Inc

Advocate & CBD Spa Owner Cindy Sovine Fights for Initiative 300, Cannabis Rights

Cindy Sovine of Sovine Consulting and Utopia Spa & Wellness Lounge is without a doubt a true “leader” and trailblazer. She does not follow the path walked by others, she looks to take the difficult path that not too many would dare to walk down because of all the obstacles …

Read More
How to Invest in Hemp Farms

Americans have all wanted to know how to invest in hemp farms since the 2018 Farm Bill was signed. The time to capitalize is right now in 2019 and sitting back one year could mean you’re missing out on the opportunity of a lifetime that may never come again.

Read More